Highest-materiality recent filing
Oaktree Specialty Lending Q3 NII $0.37/share, NAV stable at $15.70, declares $0.33 distribution
GAAP NII $32.5M ($0.37/share) vs $34.4M ($0.39) prior quarter; adjusted NII $32.2M ($0.37).
Oaktree Specialty Lending Q2 NII $0.38/sh, NAV $15.69, net loss $0.21/sh; dividend $0.34
Total investment income $70.4M ($0.80/sh), down from $75.1M ($0.85/sh) QoQ, driven by lower rates and non-recurring income.
Oaktree Specialty Lending stockholders re-elect directors, ratify auditor; special meeting adjourned
John B. Frank and Bruce Zimmerman re-elected with ~33.7M and ~33.9M votes for, respectively.
Oaktree Specialty Lending Q1 2026: adj NII $0.41/sh, NAV $16.30, dividend $0.40 covered
GAAP net investment income $36.7M ($0.42/sh); adjusted NII $36.1M ($0.41/sh), both up from prior Q.
Oaktree Specialty Lending Q4 NII $0.41/share, NAV $16.64, dividend $0.40
Total investment income $77.3M ($0.88/share) in Q4 FY2025, up from $75.3M in Q3; full year $316.8M vs $381.7M last year.
Oaktree Specialty Lending elects Brett McKeone as COO effective Dec 31, 2025
Brett McKeone, 48, named COO of Oaktree Specialty Lending Corp, effective December 31, 2025.
Oaktree Specialty Lending Q3 NII falls to $0.38/shr from $0.45; NAV flat at $16.76
GAAP NII $33.5M ($0.38/shr) vs $39.1M ($0.45) prior quarter, down due to lower income and higher interest expense.
Oaktree Specialty Lending repays and terminates OSI2 senior lending facility
Repaid all outstanding borrowings under OSI2 Facility on May 14, 2025, leading to termination.
Added SMBC Nikko Securities America, Inc. as a Placement Agent under Equity Distribution Agreement, effective May 5, 2025.
Fiscal Q2 2025: NII $0.45/share, NAV down 5% to $16.75
Total investment income $77.6M ($0.90/share) vs $86.6M ($1.05) prior quarter; NII $39.1M ($0.45) vs $44.3M ($0.54).
Oaktree Specialty Lending amends credit facility: lower margin, extended maturity to 2030
Facility size decreased from $1.218B to $1.160B; accordion increased to $1.50B or net worth.
Oaktree Specialty Lending stockholders approve below-NAV share issuance, elect director
Phyllis R. Caldwell elected to Board until 2028 annual meeting: 29.8M for, 4.7M withheld, 24.0M broker non-votes.
Oaktree Specialty Lending issues $300M 6.340% Notes due 2030
Issued $300M aggregate principal of 6.340% Notes due February 27, 2030.
Oaktree Specialty Lending prices $300M 6.340% Notes due 2030
Issued $300M aggregate principal of 6.340% Notes due 2030; net proceeds of $296.2M after discounts and expenses.
Oaktree Specialty Lending Q1 NII $0.54/sh, NAV $17.63; Oaktree buys $100M shares at NAV
Total investment income $86.6M ($1.05/sh), down from $94.7M ($1.15/sh) QoQ due to lower rates and non-accruals.
Oaktree Specialty Lending Q4 net investment income $0.55/sh; NAV $18.09; declares $0.55 dividend
Total investment income Q4 $94.7M ($1.15/sh); full year $381.7M ($4.75/sh).
Oaktree Specialty Lending increases ATM equity offering capacity by $175M to $300M total
Amendment to Equity Distribution Agreement dated Aug 2, 2024 raises aggregate offering price to $300M.
Oaktree Specialty Lending Q3 adjusted NII $0.55/sh, NAV down to $18.19
Total investment income $95.0M ($1.16/sh), up from $94.0M in prior quarter.
Oaktree Specialty Lending COO Matthew Stewart resigns effective June 14, 2024
Matthew Stewart resigned as Chief Operating Officer of Oaktree Specialty Lending Corporation.
Oaktree Specialty Lending amends credit facility, extends maturity to Jan 2029
Reinvestment period extended to May 25, 2027; final maturity extended to Jan 26, 2029.
OCSL Q2 adjusted NII $0.56/sh, NAV $18.72, permanent mgmt fee cut to 1.00%
GAAP NII $41.4M ($0.52/sh); adjusted NII $44.7M ($0.56/sh) vs $44.2M in prior quarter.
Oaktree Specialty Lending shareholders authorize below-NAV share issuance up to 25% of outstanding
Deborah Gero and Craig Jacobson elected to board until 2027 annual meeting; 28.8M and 28.9M votes for, respectively.
Oaktree Specialty Lending Q1 NII $0.57, NAV falls to $19.14, non-accruals up
GAAP NII $44.2M ($0.57/share), down from $47.5M ($0.62) in prior quarter.
Record full-year adjusted net investment income of $177.8M ($2.47/share) vs $128.6M in prior year; ROE over 12%.
Oaktree Specialty Lending issues $300M 7.100% Notes due 2029 to reduce credit facility debt
Issued $300 million principal amount of 7.100% Notes due February 15, 2029.
Oaktree Specialty Lending issues $300M of 7.100% Notes due 2029
$300M aggregate principal amount of 7.100% Notes due 2029; closing expected Aug 15, 2023.
Oaktree Specialty Lending amends equity distribution agreement; adds Jefferies as placement agent
Jefferies LLC added as Placement Agent; SMBC Nikko removed effective Aug 8, 2023.
Total investment income $101.9M; GAAP NII $48.4M ($0.63/share).
Oaktree Specialty Lending upsizes credit facility to $1.218B and extends maturities
Credit facility increased from $1.0B to $1.218B via Amendment No. 6.
Oaktree Specialty Lending upsizes credit facility to $400M, extends maturity to 2027
OSI2 Citibank Facility increased from $250M to $400M; reinvestment period extended to May 2025, maturity to Jan 2027.
Oaktree Specialty Lending Q2 fiscal 2023 NII $0.63/share; declares $0.55 dividend
Total investment income $96.3M ($1.32/share) vs $79.2M in prior quarter; driven by OSI2 merger and higher base rates.
OCSL stockholders approve below-NAV share issuance up to 25% of outstanding
Proposal passed with 82.98M votes for, 19.84M against, 1.55M abstain.
Entered amendment to equity distribution agreement dated Feb 7, 2022, with new shelf registration.
Oaktree Specialty Lending Q1 adjusted NII $0.61/share, up 10% QoQ; dividend raised to $0.55
Total investment income $79.2M ($1.30/share) vs $70.1M prior quarter; GAAP NII $38.8M ($0.63/share).
OCSL completes merger with OSI II; combined company assets >$3.3B
Combined company pro forma assets exceed $3.3B as of Dec 31, 2022.
Oaktree Specialty Lending to implement 1-for-3 reverse stock split effective Jan 23
Reverse stock split ratio of 1-for-3, subject to stockholder approval at Jan 20 annual meeting.
OCSL and OSI2 stockholders approved merger; over 96% and 89% support; close expected Jan 23, 2023.
Oaktree Specialty Lending supplements proxy disclosures in response to stockholder demand letters
Received three demand letters alleging material omissions in merger proxy; company calls them meritless.
Oaktree Specialty Lending Q4 adjusted NII $0.18/sh, dividend up to $0.18 + special $0.14
Q4 total investment income $70.1M ($0.38/sh); FY $262.5M ($1.44/sh), up 11% YoY.
OCSL and OSI II agree to merge; OCSL to issue shares based on NAV, expected Q2 2023 close
Exchange ratio based on NAV; illustrative 2.71 OCSL shares per OSI2 share (June 30 NAV).
OCSL Q3 adj NII $0.17/shr; dividend raised to $0.17; NAV $6.89, down 5.1%
GAAP NII $40.4M ($0.22/shr); adjusted NII $31.4M ($0.17/shr) vs $32.3M ($0.18) prior quarter.
Oaktree Specialty Lending Q2 NII $0.22/share; raises dividend to $0.165, up 3% QoQ
GAAP NII $40.1M ($0.22/share) vs. $32.3M ($0.18/share) prior quarter; adjusted NII $32.3M ($0.18/share).
Phyllis R. Caldwell elected director with 97.8M votes for, 2.8M withheld, 39.7M broker non-votes.
Oaktree Specialty Lending enters into $125M ATM equity distribution agreement
Entered equity distribution agreement to sell up to $125M of common stock at-the-market through multiple placement agents.
Oaktree Specialty Lending Q1 2022: adj NII $0.17/sh, NAV $7.34, div up 3% to $0.16
Total investment income $64.9M; adj total investment income $62.1M; GAAP NII $32.3M ($0.18/sh); adj NII $31.2M ($0.17/sh).
Oaktree Specialty Lending adds $50M revolving credit commitment from BNP Paribas
BNP Paribas provides $50 million commitment under Oaktree's senior secured revolving credit facility.
Oaktree Specialty Lending expands credit facility to $200M, extends maturity to Nov 2024
Facility size increased from $150M to $200M.
Oaktree Specialty Lending reports Q4 NII $0.18/sh; declares $0.155 dividend, up 7%
GAAP NII $33.0M ($0.18/sh) in Q4, down from $35.9M ($0.20/sh) in Q3; full-year NII $97.1M ($0.60/sh) vs $72.0M in FY2020.
Oaktree Specialty Lending CCO Kimberly Larin resigns effective Nov 12, 2021
Kimberly Larin resigned as Chief Compliance Officer, effective Nov 12, 2021.
Director Richard Ruben resigns from Oaktree Specialty Lending board effective Sept 24, 2021
Richard G. Ruben resigned as a director of Oaktree Specialty Lending Corporation, effective September 24, 2021.
On June 14, 2024, Matthew Stewart resigned as Chief Operating Officer of Oaktree Specialty Lending Corporation.
On October 1, 2021, Kimberly Larin notified Oaktree Specialty Lending Corporation (the “Company”) of her resignation as the Company’s Chief Compliance Officer, effective as of the close of business on November 12, 2021.
On September 22, 2021, Richard G. Ruben resigned as a member of the board of directors of Oaktree Specialty Lending Corporation (the “Company”), effective as of September 24, 2021.
Max materiality 1.00 · Median 0.60 · Most common event earnings